A comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with men

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 1, 2013, Pages 42-49

  Castle, Philip E ^a   Follansbee, Stephen ^b   Borgonovo, Sylvia ^b   Tokugawa, Diane ^d   Schwartz, Lauren M ^f   Lorey, Thomas S ^d   LaMere, Brandon ^e   Gage, Julia C ^f   Fetterman, Barbara ^d   Darragh, Teresa M ^c   Rodriguez, Ana Cecilia ^a,g   Wentzensen, Nicolas ^f  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KAISER PERMANENTE   (United States)

^e DIVISION OF RESEARCH   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g Proyecto Epidemiologico Guanacaste   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA;

ADULT; AGED; ANUS CANCER; ARTICLE; CANCER EPIDEMIOLOGY; CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC IMAGING; DNA DETERMINATION; GENOTYPE; HIGH RESOLUTION ANOSCOPY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PRECANCER; PRIORITY JOURNAL; RECTUM BIOPSY; VERRUCA VULGARIS; WART VIRUS;

ADULT; AGE DISTRIBUTION; ANUS NEOPLASMS; CROSS-SECTIONAL STUDIES; DNA, VIRAL; GENOTYPE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR; TUMOR MARKERS, BIOLOGICAL;

EID: 84872155259     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0984     Document Type: Article

References (37)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Silverberg MJ, Lau B, Justice AC, Engels E, Gill MJ, Goedert JJ, et al. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis 2012;54:1026-34.
3. Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst 2011;103:753-62.
4. Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012;13:487-500.
5. Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 2008;43(4 Suppl):S5-25.
6. Molden T, Kraus I, Karlsen F, Skomedal H, Nygard JF, Hagmar B. Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women > 30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion. Cancer Epidemiol Biomarkers Prev 2005;14:367-72.
7. Molden T, Nygard JF, Kraus I, Karlsen F, Nygard M, Skare GB, et al. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: a 2-year follow-up of women with ASCUS or LSIL Pap smear. Int J Cancer 2005;114:973-6.
8. Kraus I, Molden T, Holm R, Lie AK, Karlsen F, Kristensen GB, et al. Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas. J Clin Microbiol 2006;44:1310-7.
9. Molden T, Kraus I, Karlsen F, Skomedal H, Hagmar B. Human papillomavirus E6/E7 mRNA expression in women younger than 30 years of age. Gynecol Oncol 2006;100:95-100.
10. Molden T, Kraus I, Skomedal H, Nordstrom T, Karlsen F. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses. J Virol Methods 2007;142:204-12.
11. Sorbye SW, Fismen S, Gutteberg T, Mortensen ES. Triage of women with minor cervical lesions: data suggesting a "test and treat" approach for HPV E6/E7 mRNA testing. PLoS ONE 2010;5:e12724.
12. Valari O, Koliopoulos G, Karakitsos P, Valasoulis G, Founta C, Godevenos D, et al. Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: predictors and clinical implications. Gynecol Oncol 2011;122:505-8.
13. Silling S, Kreuter A, Hellmich M, Swoboda J, Pfi ster H, Wieland U. Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men. J Clin Virol 2012;53:325-31.
14. Szarewski A, Mesher D, Cadman L, Austin J, Ashdown-Barr L, Ho L, et al. Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the predictors 2 study. J Clin Microbiol 2012;50:1867-73.
15. Cuschieri K, Wentzensen N. Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2008;17:2536-45.
16. Mathews WC, Cachay ER, Caperna J, Sitapati A, Cosman B, Abramson I. Estimating the accuracy of anal cytology in the presence of an imperfect reference standard. PLoS ONE 2010;5:e12284.
17. Chiao EY, Giordano TP, Palefsky JM, Tyring S, El Serag H. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis 2006;43:223-33.
18. Gage JC, Ghosh A, Borgonovo S, Follansbee S, Wentzensen N, Gravitt PE, et al. A comparison of dacron versus flocked nylon swabs for anal cytology specimen collection. Acta Cytol 2011;55:364-7.
19. Darragh TM, Tokugawa D, Castle PE, Follansbee S, Borgonovo S, Lamere BJ, et al. Interrater agreement of anal cytology. Cancer Cytopathol. 2012 Jul 18. [Epub ahead of print].
20. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
21. Castle PE, Gravitt PE, Solomon D, Wheeler CM, Schiffman M. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol 2008;46:109-17.
22. Gravitt PE, Schiffman M, Solomon D, Wheeler CM, Castle PE. A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study. Cancer Epidemiol Biomarkers Prev 2008;17:1248-54.
23. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens-part B: biological agents. Lancet Oncol 2009;10:321-2.
24. Cuzick J. A Wilcoxon-type test for trend. Stat Med 1985;4:87-90.
25. Wentzensen N, Follansbee S, Borgonovo S, Tokugawa D, Schwartz L, Lorey TS, et al. HPV genotyping, HPV mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected men who have sex with men. AIDS 2012;26:2185-92.
26. Abramowitz L, Jacquard AC, Jaroud F, Haesebaert J, Siproudhis L, Pradat P, et al. Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer 2011;129:433-9.
27. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009;124:1626-36.
28. Gohy L, Gorska I, Rouleau D, Ghattas G, Pokomandy A, Vezina S, et al. Genotyping of human papillomavirus DNA in anal biopsies and anal swabs collected from HIV-seropositive men with anal dysplasia. J Acquir Immune Defic Syndr 2008;49:32-9.
29. Salit IE, Tinmouth J, Chong S, Raboud J, Diong C, Su D, et al. Screening for HIV-associated anal cancer: correlation of HPV geno-types, p16, and E6 transcripts with anal pathology. Cancer Epidemiol Biomarkers Prev 2009;18:1986-92.
30. Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, Allen RA, et al. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer 2009;125:2151-8.
31. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010;11:1048-56.
32. Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer 2009;4:8.
33. Castle PE, Dockter J, Giachetti C, Garcia FA, McCormick MK, Mitchell AL, et al. A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer. Clin Cancer Res 2007;13:2599-605.
34. Monsonego J, Hudgens MG, Zerat L, Zerat JC, Syrjanen K, Halfon P, et al. Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study. Int J Cancer 2011;129:691-701.
35. Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Luff RD, et al. The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med 2012;136:1266-97.
36. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 2006;110:525-41.
37. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012;62:147-72.